Abstract
Using a large (N= 25 493) population-based cohort from Queensland, Australia, we compared melanoma survival among cases with a single invasive melanoma only against those who also had a diagnosis of a single in situ melanoma. After adjustment for sex, age, body site, clinicopathological subtype, thickness and ulceration, it was found that there was no difference (P = 0.99) in 10-year melanoma-specific mortality following a diagnosis of an invasive lesion, whether or not an in situ melanoma was also present. We conclude that in situ melanomas do not alter the prognosis of an invasive melanoma.
| Original language | English |
|---|---|
| Pages (from-to) | 57-60 |
| Number of pages | 4 |
| Journal | The Australasian journal of dermatology |
| Volume | 57 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Feb 2016 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Cohort Studies
- Female
- Humans
- Male
- Melanoma
- Middle Aged
- Neoplasm Invasiveness
- Neoplasms, Second Primary
- Queensland
- Registries
- Skin Neoplasms
- Survival Rate
- Young Adult
- Journal Article
- Research Support, Non-U.S. Gov't
Fingerprint
Dive into the research topics of 'Diagnosis of an additional in situ melanoma does not influence survival for patients with a single invasive melanoma: A registry-based follow-up study'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver